Jiyu Wen

机构：Guangdong Medical College, Affiliated Hospital of Guangdong Medical College Hospital

发表论文 13 篇 · 总被引 761 次 · h-index 5

代表论文

• Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial (2021 · Nature Medicine · 被引 413)
• Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma (2023 · JAMA · 被引 254)
• JUPITER-02: Randomized, double-blind, phase III study of toripalimab or placebo plus gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (NPC). (2021 · Journal of Clinical Oncology · 被引 36)
• Nomogram predicting cancer-specific mortality in early-onset rectal cancer: a competing risk analysis (2020 · International Journal of Colorectal Disease · 被引 20)
• Final overall survival analysis of JUPITER-02: A phase 3 study of toripalimab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (NPC). (2023 · Journal of Clinical Oncology · 被引 5)
• Correction to: Nomogram predicting cancer-specific mortality in early-onset rectal cancer: a competing risk analysis (2020 · International Journal of Colorectal Disease · 被引 5)